VTVT
vTv Therapeutics Inc
NASDAQ: VTVT · HEALTHCARE · BIOTECHNOLOGY
$32.24
+3.10% today
Updated 2026-04-30
Market cap
$125.92M
P/E ratio
—
P/S ratio
14,852.65x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$14 – $44
Volume
0.1M
vTv Therapeutics Inc (VTVT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-41.68M | $-30.78M | $-36.95M | $-48.21M | $-44.56M | $-26.86M | $-23.02M | $-18.00M | $-19.31M | $-15.25M | $-19.08M | $-25.31M | $-25.25M |
| Capital expenditures | $181000.00 | $33000.00 | $104000.00 | $87000.00 | $57000.00 | $5000.00 | $70000.00 | $21000.00 | $21000.00 | $21000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.92M | — | $859000.00 | $2.64M | $3.65M | $2.68M | $1.52M | $1.01M | $2.36M | $1.27M | $1.58M | $2.76M | $3.77M |
| Free cash flow | $-41.87M | $-30.81M | $-37.05M | $-48.30M | $-44.62M | $-26.86M | $-23.09M | $-18.02M | $-19.33M | $-15.27M | $-19.08M | $-25.31M | $-25.25M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | — | $992000.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $86.62M | $-36.50M | $-37.09M | $-10.24M | $94000.00 | $1.47M | — | $-1.29M | — | — | — |